Papua New Guinea vs Togo: Previously treated cases tested for RR-/MDR-TB
Papua New Guinea
100.0%
in 2024
Togo
100.0%
in 2024
Papua New Guinea rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Papua New Guinea
- Togo
How they compare
Papua New Guinea currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2015 it was Togo ahead.
Papua New Guinea ranks 1st and Togo ranks 1st of 180 countries.
Across the 2 decades both report, Papua New Guinea averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Papua New Guinea | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 43.3% | 83.0% | 39.7% | Togo |
| 2020s | 100.0% | 81.5% | 18.5% | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Papua New Guinea or Togo?
- Papua New Guinea, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Papua New Guinea and Togo?
- 0.0%, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Togo?
- 5 years are reported by both, from 2015 to 2024.
- How do Papua New Guinea and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Papua New Guinea ranks 1st and Togo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.